Pulse Biosciences CS (PLSE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -49,308 | -31,269 | -17,273 | -63,660 | -48,244 |
| Depreciation Amortization | 1,019 | 680 | 326 | 1,159 | 862 |
| Accounts receivable | 56 | 53 | 40 | -61 | -72 |
| Accounts payable and accrued liabilities | -895 | -931 | 609 | 1,160 | 975 |
| Other Working Capital | -2,573 | -1,547 | -654 | -6,197 | -5,011 |
| Other Operating Activity | 12,653 | 4,598 | 1,358 | 13,502 | 10,087 |
| Operating Cash Flow | $-39,048 | $-28,416 | $-15,594 | $-54,097 | $-41,403 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -360 | -298 | -279 | -437 | -303 |
| Sale Of Investment | N/A | N/A | N/A | 8,000 | 8,000 |
| Investing Cash Flow | $-360 | $-298 | $-279 | $7,563 | $7,697 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 65,000 | N/A | N/A | 1,939 | 1,939 |
| Debt Repayment | -437 | -437 | -437 | -1,532 | -875 |
| Common Stock Issued | 15,393 | 15,335 | 372 | 62,510 | 62,402 |
| Other Financing Activity | 0 | 0 | 0 | -232 | -232 |
| Financing Cash Flow | $79,956 | $14,898 | $-65 | $62,685 | $63,234 |
| Beginning Cash Position | 28,614 | 28,614 | 28,614 | 12,463 | 12,463 |
| End Cash Position | 69,162 | 14,798 | 12,676 | 28,614 | 41,991 |
| Net Cash Flow | $40,548 | $-13,816 | $-15,938 | $16,151 | $29,528 |
| Free Cash Flow | |||||
| Operating Cash Flow | -39,048 | -28,416 | -15,594 | -54,097 | -41,403 |
| Capital Expenditure | -360 | -298 | -279 | -437 | -303 |
| Free Cash Flow | -39,408 | -28,714 | -15,873 | -54,534 | -41,706 |